Sponsored By

For information on becoming a sponsor or exhibitor, please click here.


MAY 13 - 14 2015
Genetics and Genomics
97 229 107588

Welcome to the Genetics and Genomics free online conference! The event is now available on-demand and you can attend sessions including keynotes sessions by Dr. Michael Snyder, Dr. John Quackenbush,  and Dr. Peter White

The theme of this conference is a range of genetics and genomics topics such as RNAi, Next-generation sequencing, Cancer research, Sequencing, Genome-wide association studies GWAS, Epigenetics, Mapping, Exomes, Genomic medicine, Human Genome Structural Variation, Pharmacogenetics, DNA/RNA Purification, Mutations, Translational Genomics, Bioinformatics, Genotyping, Pharmacogenomics, Screening, Cloning, Gene Expression, Phenotyping, Transcription, Functional Genomics, Synthetic Biology, Genome Engineering, Immunology, qPCR/Real-Time PCR, PCR, Biomarkers, Stem Cell research, Human Identification, Bioproduction, Molecular Diagnostics and much more.

Attendees can earn free CME, CE and CEU Credits.

This event will bring together research scientists, post docs, principal investigators, lab directors and professionals from around the world to learn about recent advances in genetics and genomics. This conference offers an amazing opportunity as it is free to participants, and there will be no out-of-pocket expenses for travel. However, participants will still benefit from interacting with a global community of like-minded colleagues, without leaving the comfort of their office or home.


Conference participants will be able to
 

  • Attend interactive live streaming video sessions
  • Have their questions answered in real-time by industry experts
  • Chat live with peers and speakers
  • Browse a virtual exhibit floor for solution providers
  • Earn free CME, CE and CEU continuing education credits


Use #BCLgenetics to follow the conversation

No crowded airports, delayed flights or expensive hotel rooms, but still the look and feel of a first-rate conference with world renowned experts. Participants also benefit from the fact that experts and vendors are more accessible, no more waiting in line to speak to someone. Think it is too good to be true? Checkout the venue and become a believer.


Speakers:
  • Professor of Computational Biology and Bioinformatics, Department of Biostatistics, Harvard University, Dana-Farber Cancer Institute
  • Professor and Chair, Genetics, Director, Stanford Center for Genomics and Personalized Medicine, Stanford University School of Medicine
  • President, Director and Faculty Investigator, HudsonAlpha Institute for Biotechnology
  • Vice President and Distinguished Scientist Illumina
  • Bioinformatics Segment Manager, Agilent Technologies
  • Director, Head of Biological research content, Qiagen, Inc.
  • Associate Director, Scientific Applications, Sample Technologies Development, Qiagen GmbH
  • Director, Product Development & Marketing, Broad Institute Genomics Platform
  • Senior Research Fellow, MSc Human Nutrition, Course Co-ordinator for Molecular Nutrition, University of Aberdeen, Rowett Institute of Nutrition and Health, Metabolic Health Group
  • Peter White, Co-Founder, Chief Scientific Advisor, GenomeNext LLC, Assistant Professor of Pediatrics, Nationwide Children's Hospital, James Hirmas, Co-Founder, CEO, GenomeNext LLC
  • Senior Director, Genomics and Content, Personalis, Inc,
  • John Alexander, Assistant Professor of Human Genetics, Director, Molecular Laboratory, Emory University School of Medicine, Christin Collins, Assistant Professor, Department of Human Genetics
  • Senior Manager, NGS Applications, DNASTAR
  • Director of the Translational Genomics Core of Partners HealthCare Personalized Medicine, Harvard Medical School
  • CEO, CSO and Co-Founder, AllSeq, Inc.
  • Head, Kinghorn Centre for Clinical Genomics, Garvan Institute; CEO, Genome.One
  • Principal Investigator, Department of Genome Sciences, University of Washington
  • Director, Center for Cancer Genetics and Prevention, Susan F. Smith Center for Women's Cancers, Dana-Farber Cancer Institute
  • Professor, Computer Science and AI Lab, Director, MIT Computational Biology Group, Broad Institute of MIT and Harvard
  • Professor, Biostatistics & Medical Informatics, University of Wisconsin - Madison
  • Senior Vice President, Chief Scientific Officer, Promosome, Adjunct Associate Professor, The Scripps Research Institute
  • Scientist, Allen Institute for Brain Science
  • Postdoctoral Research Fellow, Dana Farber Cancer Institute/Harvard University
  • Director, Center for Computational Biology McKusick-Nathans Institute of Genetic Medicine, Professor, Departments of Biomedical Engineering, Computer Science, and Biostatistics
  • Chief, Division of Computational Biomedicine, Boston University School of Medicine, Director, Translational Bioinformatics Program, Clinical and Translational Science Institute
  • Assistant Professor, School of Life Sciences, Arizona State University
  • Associate Professor, Department of Medicine, University of Colorado School of Medicine, Department of Epidemiology, Colorado School of Public Health, Integrated Center for Genes, Environment,

Show Resources
Agenda
All times are Pacific Time
  • MAY 13, 2015 05:00 AM PDT
    Next Generation Sequencing Panels in Clinical Diagnostics: Autism Spectrum Disorders and Eye Related Disorders
    Speaker: John Alexander, PhD, Christin Collins, PhD
  • MAY 13, 2015 06:00 AM PDT
    Speaker: Martin Schlumpberger, PhD
  • MAY 13, 2015 06:00 AM PDT
    Speaker: Janice Drew, PhD
  • MAY 13, 2015 07:30 AM PDT
    Speaker: John Quackenbush, PhD
    SEE ABSTRACT | Continuing Education: CEU
  • MAY 13, 2015 09:00 AM PDT
    Speaker: Gary Schroth,PhD
  • MAY 13, 2015 10:30 AM PDT
    Speaker: Peter White, PhD, James Hirmas
  • MAY 13, 2015 10:30 AM PDT
    Speaker: Christina Kendziorski, PhD
  • MAY 13, 2015 10:30 AM PDT
    Speaker: Steven Salzberg, PhD
  • MAY 13, 2015 12:00 PM PDT
    Speaker: Matthew Keyser, MS
  • MAY 13, 2015 12:00 PM PDT
    Speaker: Deanna Church, PhD
  • MAY 13, 2015 12:00 PM PDT
    Speaker: Jeremy A Miller, PhD
  • MAY 13, 2015 01:30 PM PDT
    Speaker: Carolina Livi, PhD
  • MAY 13, 2015 01:30 PM PDT
    Speaker: Manolis Kellis, PhD
  • MAY 13, 2015 01:30 PM PDT
    Speaker: Andrew Barry
  • MAY 13, 2015 03:00 PM PDT
    Speaker: Marcel Dinger, PhD
  • MAY 13, 2015 03:00 PM PDT
    Speaker: Melissa A Wilson Sayres, PhD
  • MAY 13, 2015 03:00 PM PDT
    Speaker: John Platig, PhD
  • MAY 14, 2015 06:00 AM PDT
    Next-generation sequencing for BRCA1 and BRCA2 mutation testing
    Speaker: Vikram Devgan, PhD, MBA
  • MAY 14, 2015 07:30 AM PDT
    Speaker: Richard Myers, PhD
  • MAY 14, 2015 09:00 AM PDT
    Speaker: Michael Snyder, PhD
  • MAY 14, 2015 10:30 AM PDT
    Speaker: Shawn Baker, PhD
  • MAY 14, 2015 10:30 AM PDT
    Speaker: Douglas Fowler, PhD
  • MAY 14, 2015 12:00 PM PDT
    Speaker: Sami Amr, PhD
  • MAY 14, 2015 12:00 PM PDT
    Speaker: Vincent P Mauro, PhD
  • MAY 14, 2015 01:30 PM PDT
    Speaker: Ivana Yang, PhD
  • MAY 14, 2015 01:30 PM PDT
    Speaker: Judy E Garber, MD, MPH
  • Next Gen Sequencing
  • MAY 13, 2015 05:00 AM PDT
    Next Generation Sequencing Panels in Clinical Diagnostics: Autism Spectrum Disorders and Eye Related Disorders
    Speaker: John Alexander, PhD, Christin Collins, PhD
  • MAY 13, 2015 10:30 AM PDT
    Speaker: Peter White, PhD, James Hirmas
  • MAY 13, 2015 03:00 PM PDT
    Speaker: Melissa A Wilson Sayres, PhD
  • MAY 14, 2015 06:00 AM PDT
    Next-generation sequencing for BRCA1 and BRCA2 mutation testing
    Speaker: Vikram Devgan, PhD, MBA
  • MAY 14, 2015 07:30 AM PDT
    Speaker: Richard Myers, PhD
  • MAY 14, 2015 09:00 AM PDT
    Speaker: Michael Snyder, PhD
  • MAY 14, 2015 10:30 AM PDT
    Speaker: Shawn Baker, PhD
  • MAY 14, 2015 12:00 PM PDT
    Speaker: Sami Amr, PhD
  • MAY 14, 2015 01:30 PM PDT
    Speaker: Judy E Garber, MD, MPH
  • Gene Expression Profiling
  • MAY 13, 2015 06:00 AM PDT
    Speaker: Martin Schlumpberger, PhD
  • MAY 13, 2015 09:00 AM PDT
    Speaker: Gary Schroth,PhD
  • MAY 13, 2015 10:30 AM PDT
    Speaker: Christina Kendziorski, PhD
  • MAY 13, 2015 12:00 PM PDT
    Speaker: Jeremy A Miller, PhD
  • MAY 13, 2015 01:30 PM PDT
    Speaker: Carolina Livi, PhD
  • MAY 13, 2015 03:00 PM PDT
    Speaker: Marcel Dinger, PhD
  • Industry
  • MAY 13, 2015 06:00 AM PDT
    Speaker: Janice Drew, PhD
  • MAY 13, 2015 12:00 PM PDT
    Speaker: Deanna Church, PhD
  • MAY 13, 2015 12:00 PM PDT
    Speaker: Matthew Keyser, MS
  • MAY 13, 2015 01:30 PM PDT
    Speaker: Andrew Barry
  • New Bioinformatics methods for genome analysis
  • MAY 13, 2015 07:30 AM PDT
    Speaker: John Quackenbush, PhD
    SEE ABSTRACT | Continuing Education: CEU
  • MAY 13, 2015 10:30 AM PDT
    Speaker: Steven Salzberg, PhD
  • MAY 13, 2015 01:30 PM PDT
    Speaker: Manolis Kellis, PhD
  • MAY 13, 2015 03:00 PM PDT
    Speaker: John Platig, PhD
  • A genomic view of translation and protein function
  • MAY 14, 2015 10:30 AM PDT
    Speaker: Douglas Fowler, PhD
  • MAY 14, 2015 12:00 PM PDT
    Speaker: Vincent P Mauro, PhD
  • MAY 14, 2015 01:30 PM PDT
    Speaker: Ivana Yang, PhD
Speakers

  • John Quackenbush, PhD
    Professor of Computational Biology and Bioinformatics, Department of Biostatistics, Harvard University, Dana-Farber Cancer Institute
    Biography
      John Quackenbush received his PhD in theoretical physics from UCLA in 1990. Following a physics postdoc, he received a Special Emphasis Research Career Award from the National Center for Human Genome Research to work on the Human Genome Project, spending two years at the Salk Institute and two years at Stanford University working in genomics and computational biology. In 1997 he moved to The Institute for Genomic Research (TIGR), pioneering expression analysis. He joined the Dana-Farber Cancer Institute and the Harvard School of Public Health in 2005, and works reconstruction of gene networks that drive the development of diseases. In 2012 he and Mick Correll co-Founded GenoSpace, a company that develops software tools to enable precision medicine applications. <br />
    • Michael Snyder, PhD
      Professor and Chair, Genetics, Director, Stanford Center for Genomics and Personalized Medicine, Stanford University School of Medicine
      Biography
        Michael Snyder is the Stanford Ascherman Professor and Chair of Genetics and the Director of the Center of Genomics and Personalized Medicine. Dr. Snyder received his Ph.D. training at the California Institute of Technology and carried out postdoctoral training at Stanford University. He is a leader in the field of functional genomics and proteomics, and one of the major participants of the ENCODE project. His laboratory study was the first to perform a large-scale functional genomics project in any organism, and has developed many technologies in genomics and proteomics. These including the development of proteome chips, high resolution tiling arrays for the entire human genome, methods for global mapping of transcription factor binding sites (ChIP-chip now replaced by ChIP-seq), paired end sequencing for mapping of structural variation in eukaryotes, de novo genome sequencing of genomes using high throughput technologies and RNA-Seq. These technologies have been used for characterizing genomes, proteomes and regulatory networks. Seminal findings from the Snyder laboratory include the discovery that much more of the human genome is transcribed and contains regulatory information than was previously appreciated, and a high diversity of transcription factor binding occurs both between and within species. He has also combined different state-of-the-art "omics" technologies to perform the first longitudinal detailed integrative personal omics profile (iPOP) of person and used this to assess disease risk and monitor disease states for personalized medicine. He is a cofounder of several biotechnology companies, including Protometrix (now part of Life Tehcnologies), Affomix (now part of Illumina), Excelix, and Personalis, and he presently serves on the board of a number of companies.
      • Richard Myers, PhD
        President, Director and Faculty Investigator, HudsonAlpha Institute for Biotechnology
        Biography
          Rick Myers is President, Director and Faculty Investigator at the HudsonAlpha Institute for Biotechnology, a nonprofit genomics and genetics research and teaching institute in Huntsville AL. Dr. Myers received his PhD from the University of California at Berkeley and did his postdoctoral work at Harvard University. He spent 7 years on the faculty at UCSF and 16 years at the Department of Genetics at Stanford University, where he was chair and director of the Stanford Human Genome Center. The Myers laboratory studies the human genome, with goals of understanding how allelic variation and gene expression changes contribute to human traits, including diseases, behaviors and other phenotypes. His group uses high-throughput genomic methods, including DNA sequencing, genotyping, ChIP, mRNA expression profiling, transcriptional promoter and DNA methylation measurements, as well as computational and statistical tools, to identify, characterize and understand the functional elements encoded in our genomes, and how they work together at the molecular level in normal and pathological conditions. His group also sequences whole genomes, whole exomes and targeted regions of the genome with ultrahigh-throughput DNA sequencing technologies to identify DNA sequence variants relevant to clinical and basic biological problems. The lab integrates these functional genomics, epigenetic and genetic data to understand how our genomes are involved in cancer, brain disorders, ALS, children born with developmental disorders, autoimmune diseases and other traits. In addition to research, Dr. Myers devotes considerable efforts to a variety of teaching, educational outreach, and institutional and national service activities. These include activities to increase and foster diversity in research and education, with particular emphasis in under-represented groups, as well as to help educators, legislators and the general public understand the importance of science in our everyday lives. Dr. Myers serves on numerous national and international advisory groups, including the NIH, DOE, CIRM and ResearchAmerica. He consults for the biotech industry, serving as an advisor for several companies, including Biogen Idec, Bay City Capital, Decheng Capital, Kailos Genetics, DNAnexus and IMIDomics.
        • Gary Schroth,PhD
          Vice President and Distinguished Scientist Illumina
          Biography
            Dr. Schroth is currently a Vice President and Distinguished Scientist at Illumina where he directs the Core Applications Group based in San Diego. He obtained his Ph.D. in biochemistry from the University of California at Davis and has been working in the field of next-generation sequencing (NGS) for more than a decade as part of Illumina (and Solexa). In his research Dr. Schroth uses NGS to study genomics, gene structure, expression and regulation and applies this to genomic projects in the fields of cancer, microbiology and infectious disease. Over the course of his career Dr. Schroth has published over 90 peer reviewed research papers and holds 17 U.S. patents.
          • Carolina Livi, PhD
            Bioinformatics Segment Manager, Agilent Technologies
            Biography
              Dr. Carolina Livi, has research experience in the fields of bioinformatics, regulatory biology, cancer and aging. Carolina Livi, has a Ph.D. in Molecular Developmental Biology, from the California Institute of Technology. Prior to joining Agilent, Dr. Livi worked at the University of Texas Health Science Center at San Antonio (UTHSCSA) as a Research Assistant Professor, in the department of Molecular Medicine. At Agilent, Dr. Livi is Bioinformatics Segment Manager for Life Sciences Research in Academia and Government within the Segment Marketing group.
            • Vikram Devgan, PhD, MBA
              Director, Head of Biological research content, Qiagen, Inc.
              Biography
                Dr. Devgan is the head of the Biological Research Content, QIAGEN. He received his Ph.D. in molecular biology and conducted post-doctoral research at Harvard Medical School before moving to the biotechnology industry. He received his MBA from the University of Wurzburg in Germany and has spent many years as a scientist in developing new technologies and products clinical and translational research.
              • Martin Schlumpberger, PhD
                Associate Director, Scientific Applications, Sample Technologies Development, Qiagen GmbH
                Biography
                  Martin Schlumpberger has a Ph.D. in chemistry and more than 20 years of experience working in genetics and molecular biology. He did his postdoctoral fellowship at the Institute of Neurodegenerative diseases at UCSF. He has been at QIAGEN for over 13 years developing new strategies and products, both manual and automated, to isolate nucleic acids from a wide variety of samples, including extracellular RNA and miRNA from serum and plasma, exosomal RNA, as well as intact exosomes and other extracellular vesicles (EVs). He started as a research scientist and is currently an Associate Director in the Sample Technology Development group.
                • Andrew Barry
                  Director, Product Development & Marketing, Broad Institute Genomics Platform
                  Biography
                    Andrew Barry is the Director of Product Development for the Broad Institute Genomics Platform. Andrew developed techniques for the application of NGS to studying protein interactions using phage display while earning an MS in Biomedical engineering from Tufts University. Concurrently, Andrew spent 9 years working for the Broad Institute, developing technologies for the implementation and scale-up of next generation sequencing, before leaving to work in the industrial sector. Working for Caliper Life Sciences (later acquired by PerkinElmer) he held various positions in product management, strategic marketing, and biology R&D before re-joining the Broad Institute in 2014. In his current role, Andrew is responsible for bringing the Broad Institute's genomics capabilities to the scientific community in the form of Broad Genomic Services.
                  • Janice Drew, PhD
                    Senior Research Fellow, MSc Human Nutrition, Course Co-ordinator for Molecular Nutrition, University of Aberdeen, Rowett Institute of Nutrition and Health, Metabolic Health Group
                    Biography
                      Dr. Janice Drew is a Senior Research Fellow in the Rowett Institute of Nutrition and Health within the College of Life Sciences and Medicine at the University of Aberdeen. She received a BSc Hons (First Class) degree from the University of Strathclyde (Glasgow, UK) in 1991 conducting her honours project on plant bioactives produced from genetically transformed root cultures. She pursued graduate work at the University of Durham (UK) and received her Ph.D. in molecular biology in 1994. Subsequently, Dr. Drew trained as a postdoctoral fellow in molecular neuroendocrinology, investigating G protein coupled receptor signalling in circadian rhythms and appetite and energy balance at the Rowett Research Institute (Aberdeen, UK) supported by a Strategic Alliance with Servier (France). Dr. Drew has developed research programmes in cross therapeutic areas investigating diet:gene interactions and links with gut and metabolic health. Her work utilises systems approaches incorporating genomic, proteomic, biochemical and physiological analyses to identify molecular mechanisms linking diet and lifestyle factors to gut and metabolic health. Her research in this area has investigated regulatory pathways of genes involved in key processes such as, proliferation, differentiation and apoptosis, inflammation and signalling systems such as adipokine and endocannabinoid, using in vitro cell and ex vivo human colon explant cultures, in vivo models, tissue and organ systems, blood profiling and human intervention studies. Her current focus is directed to study of the regulation and modulation of the sirtuin/NAD system as a nutrient and stress sensor and associations with metabolic health status, cancer and longevity.
                    • Peter White, PhD, James Hirmas
                      Peter White, Co-Founder, Chief Scientific Advisor, GenomeNext LLC, Assistant Professor of Pediatrics, Nationwide Children's Hospital, James Hirmas, Co-Founder, CEO, GenomeNext LLC
                      Biography
                        DR. PETER WHITE CHIEF SCIENTIFIC ADVISOR Dr. Peter White is the developer and inventor of the "Churchill" platform, and serves as GenomeNext's principal genomic scientist and technical advisor. He is a principal investigator in the Center for Microbial Pathogenesis at The Research Institute at Nationwide Children's Hospital and an Assistant Professor of Pediatrics at The Ohio State University. He is also Director of the Biomedical Genomics Core, a nationally recognized microarray and next-generation sequencing facility assisting numerous investigators in the design, production and analysis of genomics data. He is also Director of Molecular Bioinformatics, serving on the Research Computing Executive Governance Committee and the Data and Analytics Strategy Executive Committee. Dr. White has established multiple genomics initiatives as part of Nationwide Children's strategic goal to develop a cutting edge genomic medicine program. As developer and inventor of the balanced parallelization strategy for human genome analysis (named "Churchill"), Dr. White is a co-founder of GenomeNext LLC. Dr. White's research program at Nationwide Children's Hospital focuses on developing high performance computing solutions for "big data", utilizing disruptive technologies to rapidly analyze and interpret genomic data sets. Through genomic analysis of individuals, families and populations, his team is discovering genetic variation associated with diseases such as congenital heart defects, autism spectrum disorders and rare genetic diseases. Dr. White received his PhD in Molecular Biology from the University of Cambridge, England and completed his postdoctoral training in the Department of Genetics at The University of Pennsylvania, Philadelphia. He has over 15 years of experience in the field of genomics and computational biology, is the recipient of multiple awards from the National Institutes of Health and has authored over 50 peer reviewed publications. JAMES HIRMAS CHIEF EXECUTIVE OFFICER Serving as the Chief Executive Officer of GenomeNext, James Hirmas has a passion for building companies to solve some of the world's greatest challenges through the use of disruptive technology. Throughout his career, James has facilitated technological advances in commercial enterprises and has worked extensively with the US Federal Government to solve information technology and business challenges with the use of cutting edge technologies, such as cloud computing. In 2009, James lead the re-design and implementation of www.recovery.gov, the first Federal public facing website built on Amazon Web Services. In 2010, he co-founded and became the CEO of JHC Technology, a company dedicated to assisting large commercial enterprises, non-profits and public sector organizations to transition datacenter operations, IT strategy, and software development to the Cloud. While James remains a part of the JHC Technology Board of Directors, he has stepped down from his role as CEO of JHC Technology in March of 2014 in order to launch GenomeNext. James hopes that by merging cloud computing advancements, cutting edge genomic algorithms, and an expert team of passionate software developers, cloud computing engineers, and bioinformatics researchers that GenomeNext will propel genomics into an era of unparalleled discovery and innovations. James is a retired service disabled veteran of the US Armed Forces (US Army 2000 - 2004), and currently serves as a member of the DC Chapter of the Service Disabled, Veteran-Owned Small Business Council.
                      • Deanna Church, PhD
                        Senior Director, Genomics and Content, Personalis, Inc,
                        Biography
                          Deanna Church is the Senior Director of Genomics and Content at Personalis, Inc, a clinical genomics diagnostic company in Menlo Park, CA.She joined Personalis from the NCBI where she was one of the leads developing the GRCh38 reference and other bioinformatics databases. Deanna Church, Ph.D., was a staff scientist at NCBI, where she oversaw several projects concerning managing and displaying genomic data, including dbVar, a database of genomic structural variation, the NCBI Map Viewer, the Clone database, and the NCBI Remap service. Dr. Church is also a member of the Genome Reference Consortium (GRC) an international consortium charged with improving the human, mouse, and zebrafish assemblies, and was an author on the two seminal manuscripts describing the human and mouse genome sequences. She has experience in molecular biology, genetics, genomics, bioinformatics, and is currently focusing on making genomic data more useful through large-scale annotation and comparative genomics. She graduated from the University of Virginia with a BA in Liberal Arts in 1990, and received her doctoral degree in the Biological Sciences at the University of California, Irvine in 1997. She performed postdoctoral work with Dr. Janet Rossant at the Samuel Lunenfeld Research Institute at Mount Sinai Hospital in Toronto.
                        • John Alexander, PhD, Christin Collins, PhD
                          John Alexander, Assistant Professor of Human Genetics, Director, Molecular Laboratory, Emory University School of Medicine, Christin Collins, Assistant Professor, Department of Human Genetics
                          Biography
                            Dr. Alexander is an Assistant Professor in the Department of Human Genetics and a co-director of clinical molecular diagnostics at Emory Genetics Laboratory. His clinical interests include molecular diagnostics for retinal disorders in addition to general molecular diagnostics. Dr. Alexander's research interests include evaluation of recombinant adeno-associated virus based gene therapies for retinal disorders. He received his Ph.D. in genetics from the University of Florida College of Medicine and did post-doctoral fellowships at the University of Florida and the University of Alabama at Birmingham. Dr. Alexander completed his clinical molecular genetics training at the University of Alabama at Birmingham under the direction of Dr. Bruce Korf and Dr. Ludwine Messiaen. Dr. Alexander is board certified in clinical molecular genetics and is a Fellow of the American College of Medical Genetics. Dr. Collins is an Assistant Professor in the Department of Human Genetics and a co-director of the molecular laboratory at Emory Genetics Laboratory. Her research interests are in investigating the genetic causes of complex diseases, specifically autism spectrum disorders (ASD). The primary focus of her clinical work is the implementation of molecular techniques to improve clinical testing for genetic disease. She received her Ph.D. from the University of Florida and did her post-doctoral fellowship in the laboratory of Dr. Louis Kunkel at the Children's Hospital Boston. Dr. Collins completed her clinical molecular genetics training at Harvard Medical School and is board certified in Clinical Molecular Genetics.
                          • Matthew Keyser, MS
                            Senior Manager, NGS Applications, DNASTAR
                            Biography
                              Matthew Keyser is Senior Manager, NGS Applications for DNASTAR, where he has helped scientists address their sequence assembly and analysis challenges for the past seven years. Matts sole focus at DNASTAR is supporting customers in next-gen sequencing applications using DNASTARs broad software toolset. Matt helps customers with their templated and de novo assembly projects, transcriptomes, exomes, metagenomic assemblies, RNA-Seq, ChIP-Seq and numerous other unique experiments. Matt has helped hundreds of scientists optimize their workflows using DNASTARs next-gen software solutions. He has also spoken at numerous conferences and workshops regarding the capabilities of DNASTARs next-gen software tools.
                            • Sami Amr, PhD
                              Director of the Translational Genomics Core of Partners HealthCare Personalized Medicine, Harvard Medical School
                              Biography
                                Sami Amr is the Director of the Translational Genomics Core of Partners HealthCare Personalized Medicine where he feels privileged to work with basic and translational researchers across Partners Healthcare to identify DNA, RNA, and methylation markers and signatures of disease that can help de-convolute underlying mechanisms of pathogenesis as well as be leveraged in diagnostic and clinical assays.
                              • Shawn Baker, PhD
                                CEO, CSO and Co-Founder, AllSeq, Inc.
                                Biography
                                  Dr. Shawn C. Baker is the Chief Science Officer and co-founder of AllSeq. Having received his Ph.D. at the University of California - Davis, he started his career as a Research Scientist at Illumina when it was a 15-person startup. After spending several years at the bench developing gene expression array products, he transitioned to Product Marketing where he led a team in charge of Illuminas Expression and Regulation sequencing portfolio. In 2013 Dr. Baker co-founded AllSeq, establishing the only true sequencing marketplace, matching researchers with service providers based on their needs. <br />
                                • Marcel Dinger, PhD
                                  Head, Kinghorn Centre for Clinical Genomics, Garvan Institute; CEO, Genome.One
                                  Biography
                                    Marcel Dinger is the Founding CEO of Genome.One, Head of the Kinghorn Centre for Clinical Genomics (KCCG) at the Garvan Institute of Medical Research and conjoint Associate Professor at UNSW Australia. Genome.One is a world-class clinical genomics service and develops specialist software and analytics solutions to enable precision healthcare worldwide. Genome.One was one of the first companies in the world to implement the HiSeq X Ten genome sequencing platform, which has capacity to sequence 18,000 human genomes per year, and provide a disease diagnostics service based on whole genome sequencing. He has worked in bioinformatics and genomics since 1998 in both commercial and academic capacities. He was awarded his PhD in 2003 from the University of Waikato in New Zealand, has published >90 papers attracting more than 10,000 citations, and is recipient of several highly competitive awards and fellowships. He is also a founder of two other successful start-up companies. In 2016, Marcel was admitted as a Fellow into the Faculty of Sciences of the Royal College of Pathologists of Australiasia and is a Graduate of the Australian Institute of Company Directors.
                                  • Douglas Fowler, PhD
                                    Principal Investigator, Department of Genome Sciences, University of Washington
                                    Biography
                                      Dr. Fowler focuses on developing and implementing new technologies to address difficult problems in protein science and genomics. He is currently an Assistant Professor of Genome Sciences and Affiliate Assistant Professor of Bioengineering at the University of Washington in Seattle. His lab works to understand how variation in protein coding regions of the genome relates to disease, as well as to develop new methods for understanding proteins. Dr. Fowler's did his graduate work at The Scripps Research Institute, where he discovered and characterized the first mammalian functional amyloid protein, Pmel17. During his postdoctoral work at the University of Washington, he developed high-throughput methods for analyzing the effect of mutations on protein function.
                                    • Judy E Garber, MD, MPH
                                      Director, Center for Cancer Genetics and Prevention, Susan F. Smith Center for Women&#039;s Cancers, Dana-Farber Cancer Institute
                                      Biography
                                        Dr. Garber received her MD and MPH in 1981 from Yale University School of Medicine. She served her internal medicine residency at Brigham and Women's Hospital, followed by fellowships in hematology at BWH, medical oncology at DFCI, and biostatistics at the National Cancer Institute. She joined DFCI as a fellow in 1985, and now works as a medical oncologist and clinical cancer geneticist. <br /> <br />
                                      • Manolis Kellis, PhD
                                        Professor, Computer Science and AI Lab, Director, MIT Computational Biology Group, Broad Institute of MIT and Harvard
                                        Biography
                                          Manolis Kellis is a Professor of Computer Science at MIT, where he directs the MIT Computational Biology Group (compbio.mit.edu). He has helped direct several large-scale genomics projects, including the NIH Roadmap Epigenomics project, the comparative analysis of 29 mammals, the Encyclopedia of DNA Elements (ENCODE) project, and the Genotype Tissue-Expression (GTEx) project. He received the US Presidential Early Career Award in Science and Engineering (PECASE), the NSF CAREER award, the Alfred P. Sloan Fellowship. He obtained his Ph.D. from MIT, where he received the Sprowls award for the best doctorate thesis in computer science. He lived in Greece and France before moving to the US.
                                        • Christina Kendziorski, PhD
                                          Professor, Biostatistics & Medical Informatics, University of Wisconsin - Madison
                                          Biography
                                            I am a Professor in the Department of Biostatistics and Medical Informatics at UW-Madison, and an Affiliate Faculty Member in the Department of Statistics. My research is motivated by questions arising in studies of genetics and genomics, specifically as they pertain to complex diseases and personalized genomic medicine. In particular, my research group has developed statistical methods to address several questions in the design and analysis of static and time course microarray experiments, expression quantitative trait loci (eQTL) mapping, network reconstruction, next-generation sequencing experiments, and most recently personalized genomic medicine. I am fortunate to serve on the editorial boards of the Annals of Applied Statistics, Bayesian Analysis, Genetics, and the Genomics, Bioinformatics, and Systems Biology Section of Biology Direct and to be a permanent member of the NIH Genomics, Computational Biology, and Technology (GCAT) study section. I am also the head of Statistical Genetics and Genomics at UW-Madison's Institute for Clinical and Translational Research (ICTR). In addition to being PI on an NIGMS R01 to develop statistical methods for data analysis and integration in genomic based studies of disease, I am co-PI on an NSF grant for statistical modeling and inference of vast matrices for complex problems, and co-I on 6 other NIH grants.
                                          • Vincent P Mauro, PhD
                                            Senior Vice President, Chief Scientific Officer, Promosome, Adjunct Associate Professor, The Scripps Research Institute
                                            Biography
                                              Dr. Mauro received his Ph.D. from McGill University in Canada and his post-doctoral training at the Rockefeller University. At the Scripps Research Institute, Dr. Mauro established a laboratory focused on understanding fundamental mechanisms of translation initiation. These studies provided the first demonstration of mRNA-rRNA base-pairing as a translation initiation mechanism in eukaryotes and led to the identification of cis-regulatory elements in mRNAs, including translation enhancing elements. Dr. Mauro cofounded Promosome, a biotechnology company that uses technologies pioneered in his laboratory as the basis for protein expression platforms and for expression of hard-to-express proteins with significant therapeutic or industrial value.
                                            • Jeremy A Miller, PhD
                                              Scientist, Allen Institute for Brain Science
                                              Biography
                                                Jeremy Miller joined the Allen Institute in 2011 to help with computational data analysis of the Allen Human Brain Atlas project, and is currently extending his study to transcriptional atlases of the developing human and non-human primate brain. He is interested in using large-scale gene expression data to identify essential components (i.e., cell types) of the mammalian brain, as well as molecular pathways unique to human. Miller received a B.A. in mathematics and a B.S. in astronomy from the University of Maryland, and was subsequently a researcher at Los Alamos National Laboratory, where he used computer models to study the mammalian retina. Miller received his Ph.D. in neuroscience from UCLA, where he studied gene expression changes in the brain in Alzheimer's disease and normal aging. <br />
                                              • John Platig, PhD
                                                Postdoctoral Research Fellow, Dana Farber Cancer Institute/Harvard University
                                                Biography
                                                  John Platig received his PhD in Physics from the University of Maryland. His thesis focused on the applications of complex network methods to biological data sets, with an emphasis on understanding how errors in edge identification affect network properties. In conjunction with his physics training, he was a Cancer Research Training Fellow at the National Cancer Institute, working to identify potential therapeutic targets from a reconstructed gene regulatory network in Diffuse Large B Cell Lymphoma. In 2013 John started as postdoctoral fellow with John Quackenbush at the Dana-Farber Cancer Institute. He is currently working on network inference and clustering methods to better understand genetic and other factors that drive phenotypes.
                                                • Steven Salzberg, PhD
                                                  Director, Center for Computational Biology McKusick-Nathans Institute of Genetic Medicine, Professor, Departments of Biomedical Engineering, Computer Science, and Biostatistics
                                                  Biography
                                                    Steven Salzberg is a Professor of Biomedical Engineering, Computer Science, and Biostatistics and the Director of the Center for Computational Biology in the McKusick-Nathans Institute of Genetic Medicine at Johns Hopkins University. He earned his B.A. and M.S. degrees from Yale University, and his Ph.D. from Harvard University. From 1997-2005 he was Senior Director of Bioinformatics at The Institute for Genomic Research (TIGR) in Rockville, Maryland. From 2005-2011, he was the Director of the Center for Bioinformatics and Computational Biology (CBCB) and the Horvitz Professor of Computer Science at the University of Maryland, College Park. Dr. Salzberg's interest in the human genome project motivated him to develop one of the first computational gene-finding systems for the human genome in the early 1990s. His initial collaborations with TIGR at that time led to the development of a gene-finding program, Glimmer, that has been used in the analysis of thousands of microbial genomes, including Borrelia burgdorferi, Mycobacterium tuberculosis, Vibrio cholerae, Bacillus anthracis, and many others. He was a co-founder of the Influenza Genome Sequencing Project, the first large-scale genomics study of human and avian influenza viruses. His current work focuses on algorithms for genome assembly and alignment, particularly emphasizing next-generation sequencing data. In recent years his group developed the Bowtie, TopHat, Cufflinks, and StringTie software for alignment of next-gen sequences from re-sequencing and RNA-seq experiments. All of his group's software is free and open source. Dr. Salzberg has authored or co-authored two books and over 200 publications in leading scientific journals. He was the 2013 winner of the Benjamin Franklin Award for Open Access in the Life Sciences, and the 2013 winner of the Robert G. Balles Prize in Critical Thinking for his Forbes science blog. In 2001 and again in 2014 he was listed as a Highly Cited Researcher by Thomson Reuters, a compilation of the 1% most-cited researchers in the world; his H-index is 110. He is a Fellow of the American Association for the Advancement of Science and of the International Society for Computational Biology. Salzberg Lab: http://salzberg-lab.org/
                                                  • Avrum Spira, MD, MSc
                                                    Chief, Division of Computational Biomedicine, Boston University School of Medicine, Director, Translational Bioinformatics Program, Clinical and Translational Science Institute
                                                    Biography
                                                      Professor of Medicine, Pathology & Laboratory Medicine, and Bioinformatics, Alexander Graham Bell Professor of Healthcare Entrepreneurship Avrum Spira, M.D., M.Sc. is a Professor of Medicine, Pathology and Bioinformatics and the Alexander Graham Bell Professor in Health Care Entrepreneurship at Boston University. He is founding Chief of the Division of Computational Biomedicine in the Department of Medicine at Boston University and Director of the Translational Bioinformatics Program at Boston University's Clinical and Translational Science Institute. As an active clinician-scientist, he is a Pulmonary Attending in the Medical Intensive Care Unit at Boston Medical Center. He was elected to the American Society for Clinical Investigation (ASCI) in 2010, and he currently serves as a member of the NIH's Cancer Biomarker Study Section, a Senior Editor at Cancer Prevention Research and an Associate Editor at the American Journal of Respiratory and Critical Care Medicine.
                                                    • Melissa A Wilson Sayres, PhD
                                                      Assistant Professor, School of Life Sciences, Arizona State University
                                                      Biography
                                                        Dr. Wilson Sayres is actively working to understand the evolution of sex chromosomes (X and Y in mammals), and also interested in using the unique properties of these chromosomes (e.g., that they spend different amounts of time in the male and female germlines, and are subject to different selective pressures) to address how mutations accumulate. To address the first area of interest, she is cataloging and interpreting variation among Y chromosomes from populations around the world. She is also comparing diversity on the sex chromosomes and non-sex chromosomes across hundreds of individuals to determine how population demography, selection, and sex-specific mutation processes combine to contribute to the accumulation of mutations in the human genome. <br />
                                                      • Ivana Yang, PhD
                                                        Associate Professor, Department of Medicine, University of Colorado School of Medicine, Department of Epidemiology, Colorado School of Public Health, Integrated Center for Genes, Environment,
                                                        Biography
                                                          I have a broad background in genomics, genetics, and bioinformatics. As a postdoctoral fellow with John Quackenbush, I identified gene expression fingerprints for molecular classification of tumors and outcome prediction in colon cancer. As an Assistant Research Professor at Duke University and then a Staff Scientist at the National Institutes of Health (NIH), I worked with David Schwartz to identify novel innate immune genes in mice by using genetic and genomic approaches. As the Deputy Director for the Center for Genes, Environment and Health, I provided oversight of next-generation sequencing, expression profiling, genotyping, and epigenomic technologies at National Jewish Health. My current research broadly centers on the role of genetic and epigenetic factors in complex diseases. The overarching goals of my research are to use genetics and genomics to enhance early detection, predict outcome, develop biomarkers, and design personalized therapeutic strategies in non-malignant diseases. Specific current disease areas of interest include asthma and allergy, pulmonary fibrosis, chronic beryllium disease, diabetes and obesity. Human cohorts as well as animal and cell models are used to pursue these studies.
                                                        Continuing Education (CME/CE/CEU) Credits

                                                        The speakers below have been approved for CME, CE, or CEU credits. To redeem your credits, locate the presentation you watched and click on the CME/CE/CEU buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here


                                                        Committee

                                                        To download the Program Committee brochure here.


                                                        • Alan Wright, MD

                                                          Dr. Wright is the Chief Medical Officer at Roche Diagnostics Corporation in Indianapolis, Indiana. Prior to joining Roche, Dr. Wright served as Senior Vice President of Health Improvement Strategies for Miraca Life Sciences. He was the Vice President for Product Strategy and ...

                                                          See more See less
                                                        • Tatjana Matejic, PhD, D(ABMLI)

                                                        • Mark Marzinke, PhD, BABCC

                                                          Mark Marzinke, PhD, DABCC earned a Ph.D. in Biochemistry from the University of Wisconsin-Madison and subsequently completed a clinical chemistry fellowship at The Johns Hopkins University in 2012. During his clinical fellowship, Dr. Marzinke focused on the development and ...

                                                          See more See less
                                                        • Alan Maisel, MD

                                                          Dr. Alan Maisel attended University of Michigan Medical School and did his cardiology training at the University of California at San Diego. He is currently Professor of Medicine at the University and director of the coronary care unit and the heart failure program at the ...

                                                          See more See less
                                                        • Ariel Louwrier PhD

                                                          Successful Senior Scientific Business Executive with demonstrated expertise growing markets, revenues, product pipelines and expanding technical organizations into new business opportunities. Educational and business management experience in global markets, with quantified ...

                                                          See more See less
                                                        • Martin Latterich, PhD

                                                          The discovery of proteinaceous disease biomarkers and their clinical validation is critically important for the enablement of molecular diagnostics and ultimately, precision medicine. In spite of the importance of biomarkers, research done in the last two decades has yielded ...

                                                          See more See less
                                                        • Fred Russell Kramer, PhD

                                                        • Kamisha Johnson-Davis, PhD, DABCC, FACB

                                                          Dr. Johnson-Davis is a medical director of the Clinical Toxicology laboratory, Antifungal Testing and Immunosuppressants Testing at ARUP. Dr. Johnson-Davis received her PhD in pharmacology at the University of Utah and is board certified in clinical chemistry by the American ...

                                                          See more See less
                                                        • Daniel Irimia, MD, PhD

                                                        • Michael Holick, MD, PhD

                                                          Michael F. Holick, Ph.D., M.D. is Professor of Medicine, Physiology and Biophysics; Director of the General Clinical Research Unit; and Director of the Bone Health Care Clinic and the Director of the Vitamin D, Skin and Bone Research Laboratory at Boston University Medical ...

                                                          See more See less
                                                        • Bruce Hollis, PhD

                                                          Bruce W. Hollis, Ph.D. received his B.Sc. and M.Sc. from the Ohio State University and subsequently his Ph.D. from the University of Guelph in 1979. Dr. Hollis then completed an Endocrine Fellowship at The Case Western Reserve University School of Medicine in 1982. Dr. Hollis ...

                                                          See more See less
                                                        • Paul Mathews, PhD

                                                          Dr. Paul J. Mathews received his bachelors degree from the University of Oregon where he studied invertebrate behavioral plasticity in the lab of Dr. Nathan Tublitz. He received his Ph.D. in neuroscience from the University of Texas at Austin under the mentorship of Dr. Nace ...

                                                          See more See less
                                                        • Ross J Molinaro, PhD, MT(ASCP), DABCC, FACB

                                                          Ross J. Molinaro, PhD, MT(ASCP), DABCC, FACB is an Assistant Professor in the Department of Pathology and Laboratory Medicine at Emory University. He received his PhD in Clinical Chemistry and Molecular Medicine from Cleveland State University and completed the ComACC training ...

                                                          See more See less
                                                        • Howard Morris, PhD, FAACB, FFSc(RCPA)

                                                          Professor Howard Morris is Professor of Medical Sciences at the University of South Australia and a Chief Medical Scientist in Chemical Pathology at SA Pathology, Adelaide, South Australia. He is currently Vice-President of the International Federation of Clinical Chemistry ...

                                                          See more See less
                                                        • Stephanie Willerth, PhD

                                                          Dr. Willerth currently holds a Canada Research Chair in Biomedical Engineering at the University of Victoria where she is dually appointed in the Department of Mechanical Engineering and Division of Medical Sciences. Her research group investigates how to engineer neural tissue ...

                                                          See more See less
                                                        • Kathryn Wellen, PhD

                                                        • Bart C. Weimer, PhD

                                                        • Sihe Wang, PhD DABCC FACB

                                                          Dr. Sihe Wang is Section Head and Medical Director of Clinical Biochemistry and Director of Clinical Biochemistry Fellowship Training Program, Cleveland Clinic, Cleveland, Ohio. He also chairs the clinical chemistry integration effort for the Cleveland Clinic Health System which ...

                                                          See more See less
                                                        • Katerina Venderova, PharmD, PhD

                                                          Dr. Katerina Venderova obtained her master's and doctorate degrees in pharmacy, and her PhD in Toxicology from Charles University in the Czech Republic. She then received a fellowship from the Parkinson Society Canada and pursued her postdoctoral training at Toronto Western ...

                                                          See more See less
                                                        • Leigh Anne Swayne, PhD

                                                        • Joely Straseski, PhD, MS, MT(ASCP), DABCC

                                                          Dr. Straseski is a medical director of endocrinology at ARUP Laboratories and an assistant professor of pathology at the University of Utah School of Medicine. She received her PhD in pathology and laboratory medicine and a Master's degree in bacteriology from the University of ...

                                                          See more See less
                                                        • Ahmad Salehi, MD, PhD

                                                          Ahmad Salehi, M.D., Ph.D. is a Clinical Associate Professor at the Department of Psychiatry and Behavioral Sciences, Stanford Medical School and the Director of the Translational Laboratory at the VA Palo Alto Health Care System in California. He obtained his MD in Tehran, Iran ...

                                                          See more See less
                                                        • Amy K Saenger, PhD, DABCC, FACB

                                                        • Judd Moul, MD, FACS

                                                          Judd W. Moul is James H. Semans, MD Professor of Surgery, Division of Urologic Surgery, and Director of the Duke Prostate Center, Duke Cancer Institute at Duke University Medical Center. Prior to joining Duke, he was Professor of Surgery at the Uniformed Services University of ...

                                                          See more See less
                                                        • Ulrich Hengst, PhD

                                                          Dr. Ulrich Hengst studied biochemistry at the Ruhr University Bochum, Germany, and conducted his graduate research at the Friedrich Miescher Institute for Biomedical Research in Basel, Switzerland, in the group of Prof. Denis Monard. In 2003 he received his PhD from the ...

                                                          See more See less
                                                        • Anthony Grace, PhD

                                                          Dr. Anthony A. Grace is a Distinguished Professor of Neuroscience and a Professor of Psychiatry and Psychology at the University of Pittsburgh in Pittsburgh, PA. He received his Ph.D. from Yale University School of Medicine with Dr. Benjamin S. Bunney and had postdoctoral ...

                                                          See more See less
                                                        • Pierre-Antoine Gourraud, PhD, MPH

                                                          Pierre-Antoine Gourraud is a former student of the Ecole Normale Suprieure de Lyon in France. After receiving an M.P.H. from University Paris XIII in 2002, he got his Ph.D. in Immunogenetic Epidemiology and Public Health from Toulouse University in 2005. He relocated to the ...

                                                          See more See less
                                                        • Yue Wan, PhD

                                                          Yue Wan received her B.Sc in Cell Biology and Biochemistry from the University of California, San Diego. She obtained her Ph.D in Cancer Biology Stanford University, California, USA, under the mentorship of Howard Y. Chang. During her PhD, she developed the first ...

                                                          See more See less
                                                        • Theral Timpson

                                                        • Deanne Taylor, MS, PhD

                                                          Dr. Taylors background is in biophysics, bioinformatics, computational biology and structural biology with emphasis on human genetics and translational medicine. She obtained her Ph.D. in Biophysics from the University of Michigan, Ann Arbor, and completed a postdoctoral ...

                                                          See more See less
                                                        • John Quackenbush, PhD

                                                          John Quackenbush received his PhD in 1990 in theoretical physics from UCLA working on string theory models. Following two years as a postdoctoral fellow in physics, Dr. Quackenbush applied for and received a Special Emphasis Research Career Award from the National Center for ...

                                                          See more See less
                                                        • Vincent Mauro, Ph.D.

                                                          Dr. Mauro is an Associate Professor in the Department of Neurobiology at the Scripps Research Institute in La Jolla, California. He is also a co-founder and lead scientist of Promosome, a biotechnology company focused on bioproduction enablement and DNA vaccines. In addition, Dr ...

                                                          See more See less
                                                        • C Jimmy Lin, MD, PhD, MHS

                                                          Jimmy Lin, MD, PhD, MHS, is a 2012 TED Fellow and Founder & President of Rare Genomics Institute, the world's first platform to enable any community to leverage cutting-edge biotechnology to advance understanding of any rare disease. Partnering with 18 of the top medical ...

                                                          See more See less
                                                        • Agnieszka Lichanzka Ph.D.

                                                          Agnieszka is currently a Staff Scientist and Laboratory Manager at TessArae, LLC in Sterling, VA, USA. She obtained her PhD at the University of Queensland in Australia in a field of biochemistry, and subsequently worked as a post-doctoral fellow at Queen's University of Belfast ...

                                                          See more See less
                                                        • Wieslaw Furmaga, MD

                                                          Director, Clinical Chemistry Laboratory University Hospital Director, General Laboratory Cancer Treatment Research Center Director, Proteomics Laboratory UTHSC at San Antonio Interim Director, Molecular Laboratory UTHSC at San Antonio Associate Director, Mycology Laboratory UTHSC ...

                                                          See more See less
                                                        • Charles Cantor, PhD

                                                          Dr. Charles Cantor is a founder, and Chief Scientific Officer at SEQUENOM, Inc., which is a genetics discovery company with tools, information and strategies for determining the medical impact of genes and genetic variations. He is also the founder of SelectX Pharmaceuticals ...

                                                          See more See less
                                                        • Pinar Bayrak-Toydemir, MD, PhD

                                                          Dr. Bayrak-Toydemir is the medical director of the Molecular Genetics and Genomics Laboratories at ARUP and an associate professor of pathology at the University of Utah School of Medicine. Dr. Bayrak-Toydemir received her MD from the Ankara University School of Medicine in ...

                                                          See more See less
                                                        • R. Claudio Aguilar, Ph.D.

                                                          Dr. Aguilar obtained his PhD degree in Immunochemistry from the School of Pharmacy and Biochemistry, University of Buenos Aires, Argentina. Dr. Aguilar pursued his post-doctoral training at the National institutes of Health in Bethesda, MD in the lab of the well-known cell ...

                                                          See more See less
                                                        • Ottavio Arancio MD, Ph.D

                                                          Dr. Ottavio Arancio received his Ph.D and M.D. from the University of Pisa (Italy). From 1981 to 1986 he took residency training in Neurology at the University of Verona (Italy). Dr. Arancio has held Faculty appointments at Columbia University, NYU School of Medicine and at ...

                                                          See more See less
                                                        • Szczepan Baran, VMD, MS

                                                          Dr. Szczepan Baran is the Global Head, Animal Welfare and Compliance Training at Novartis Institutes for Biomedical Research. Dr. Baran received a Bachelor of Science in Pre-Veterinary Medicine from the University of Delaware, a Veterinary Medical Doctoral degree from the ...

                                                          See more See less
                                                        • Eric Gluck, MD, JD

                                                        • Sharon Geaghan, MD

                                                          Dr. Geaghan is Chief, Pathology at Lucile Packard Children's Hospital at Stanford, and Co-Director of Clinical Laboratories at Stanford Hospital and Clinics. She also directs the Bass Pediatric Cancer Center Laboratory at the Lucile Packard Hospital; is Director of the Point of ...

                                                          See more See less
                                                        • George Fritsma, MS, MT

                                                          George Fritsma is an associate professor in Laboratory Medicine of the Department of Pathology at the University of Alabama at Birmingham. Prof. Fritsma manages www.fritsmafactor.com, "The Fritsma Factor, Your Interactive Hemostasis Resource," a clinical coagulation ...

                                                          See more See less
                                                        • Bradley Ford, MD, PhD

                                                          Bradley Ford received his M.D. and Ph.D. (Physiology and Biophysics) degrees from SUNY Stony Brook, followed by a Clinical Pathology residency and postdoctoral training in basic and clinical microbiology at Washington University in St. Louis. His research interests include ...

                                                          See more See less
                                                        • David Carpentieri, MD

                                                        • Cynthia Bowman MD

                                                          Dr. Cynthia Bowman has been a broad based general pathologist for over 30 years. She graduated with a BA in Chemistry from St. Olaf College, received her MD from Vanderbilt University Medical School, and trained for 6 years at the University of California, San Francisco as a ...

                                                          See more See less
                                                        • Christoph H. Borchers, Ph.D.

                                                          Dr. Borchers received his B.S., M.S. and Ph.D. from the University of Konstanz, Germany. After his post-doctoral training and employment as a staff scientist at NIEHS/NIH/RTP, NC and he was the director of the Duke - UNC Proteomics Facility and held a faculty position at UNC ...

                                                          See more See less
                                                        • Josip Blonder, MD

                                                          Dr. Blonder leads the Clinical Proteomics Group at the CRTP/FNL. FNL is a Federally Funded Research and Development Center operated by Leidos Biomedical Research, Inc., for the National Cancer Institute (NCI). In 1978, Dr. Blonder received his M.D. at the Rijeka University ...

                                                          See more See less
                                                        • Peter Blume-Jensen, MD, PhD

                                                          Dr. Peter Blume-Jensen has extensive expertise in basic and translational cancer research, oncogenic signaling, and targeted oncology therapeutics drug discovery prior to joining Metamark as CSO in 2010.&nbsp; From 2001 to 2008 Peter was department head at first Serono, US and ...

                                                          See more See less
                                                        • Antonio Baines, PhD

                                                          Dr. Antonio T. Baines is an Associate Professor in the Department of Biology at North Carolina Central University (NCCU) and an adjunct professor in the Department of Pharmacology in the School of Medicine at the University of North Carolina (UNC) Chapel Hill. He earned a ...

                                                          See more See less
                                                        • Timothy Harris, PhD

                                                          Since June 2011, Dr. Harris has served as the Senior Vice President of Translational Medicine at Biogen Idec. Dr. Harris has served as the Director of the Advanced Technology Program at SAIC Frederick since 2007 and Chief Technology Officer for SAIC Frederick since 2008. Prior to ...

                                                          See more See less
                                                        Help

                                                        General LabRoots Questions

                                                        For bugs, spam, technical support or questions please call +1-714-463-4673 or email support@labroots.com  
                                                        Contact us

                                                        Virtual Events and Webinars

                                                        Supported Configurations

                                                        • Operating System Internet Explorer Firefox Chrome Safari
                                                          Vista IE8+ FF10+ Chrome15+
                                                          Windows 7 IE8+ FF10+ Chrome15+
                                                          Windows 8 IE10 FF10+ Chrome15+
                                                          Mac OS X   FF10+ Chrome15+ Safari5.1+
                                                        • Cookie settings: session cookies enabled
                                                        • Browser configuration must have JavaScript enabled
                                                        • Adobe Flash player 10.2 or later

                                                        To watch our webinars and virtual events a modern browser such as Chrome, Firefox, Safari, or an updated version of Internet Explorer is required.

                                                        Internet Connection

                                                        • A minimum of 100Kbps is recommended for audio-only events
                                                        • A minimum of 300Kbps is recommended for speaker on-video events

                                                        Computer Equipment

                                                        • Screen Resolution: Minimum 1024x768
                                                        • Video Card: 65,000 colors minimum
                                                        • Sound card and speakers (or headphones) for hearing webcast in full format
                                                        • Audio Card: 16-bit minimum
                                                        • RAM: 512MB of free RAM

                                                        Firewall Protocol

                                                        • HTTP on port 80 or HTTPS on port 443
                                                        • Adobe RTMP on port 1935, 80, or 443 with automatic fall-back to RTMPT (RTMP tunneling) on ports 1935, 80 or 443
                                                        • RTMPE (RTMP encrypted) on ports 1935, 80 or 443

                                                        Work-At-Home Attendees

                                                        • If a corporate VPN is used, confirm that your network traffic is not directed over the company VPN. If it is, please turn off the VPN while attending the virtual event.

                                                        For A Seamless Experience

                                                        When using a mobile device, FREE Mobile Apps are available:

                                                        - For viewing Webinars:

                                                        - For viewing Virtual Events

                                                        Attendee Guide

                                                        • To learn more about how the virtual event works for attendees, download the Attendee Guide (PDF).

                                                        Virtual Event and Webinar Support:

                                                        Continuing Education (CME/CE) Support

                                                        Loading Comments...
                                                        Show Resources